Answers are grounded in this paper and cite their sources.
A novel, potent series of indole analogs were recently developed as MR antagonists, culminating in 14. This compound represents the first MR antagonist in this class of molecules, exhibiting picomolar binding affinity and in vivo blood pressure lowering at pharmaceutically relevant doses.
No takes yet. Share an insight, caveat, or question.
Bell et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: